









Health Technology Assessment: The Role of 
Total Cost of Ownership 
 
Eoghan McConalogue, Paul Davis, Regina Connolly 




Background: Recently the European Union, through its Horizon 2020 fund has awarded 
numerous research projects tasked with the development of cloud-based health 
technology solutions. A number of these projects have a specific focus on ambient 
assisted living (AAL) technologies; solutions that offer a unique opportunity to improve 
the quality of life of persons with mild cognitive impairments. The diffusion of these 
solutions across a European wide cloud infrastructure presents a novel opportunity to 
reduce economic pressures currently experienced by European health systems. 
However, no route to market framework currently exists for a European wide 
healthcare delivery system. Objectives: The goal of the paper is to conduct the review 
and develop the literature around technology assessment for AAL technologies and 
route to market frameworks. Methods/Approach: We highlight the role of Total Cost of 
Ownership (TCO) when conducting a technology assessment by reviewing existent 
literature. Results: We discuss three TCO models that can support the assessment of 
AAL technologies. Conclusions: There is a gap in the analysis of TCO models in the 
context of AAL technologies particularly in public and private sector collaborations. 
TCO process should be developed into a key award criterion when conducting AAL 
technology assessment and procurements, thus aiding long term strategic decision 
making. 
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World age profiles are changing. Recent research publications suggest the most 
extreme population changes are to be expected in western Europe and northern 
Asia, specifically Japan. Immediate changes are more apparent in the Japanese 
population where almost one quarter of the population is already over the age of 60. 
It is predicted that almost half of the Japanese population will be over the age of 60 
the year 2060. While the projected population changes are not as severe in Europe it 
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this age 2 to 1 by 2060 (Eurostat, 2011; SBJ, 2011). While in 2011 there were 535,393 
people over the age of 65 in Ireland, a 14% increase from 2005 (Central Statistics 
Office, 2012).  
 In tandem with a change in world age profiles has been the development of 
ambient assisted technologies (AAL), (Novitzky et al., 2015; Jacquemard et al., 2014). 
AAL technologies attempt to utilise sensory and cloud technologies as an eHealth 
solution. It is envisioned that these solutions will provide assistance and support to 
persons suffering various diseases such as cardio vascular disease (CVD) and mild 
cognitive impairment (MCI). Two horizon 2020 projects are currently tasked with the 
development of AAL technologies. These projects are timely, as age profiles develop 
so too will age related diseases. It is therefore imperative that efforts are made to 
research and develop technologies that can improve the expected quality of life 
(QoL) of persons suffering with MCI and such diseases. Moreover, the inevitable 
pressure that health care systems will feel require a degree of scenario planning and 
research that might lessen this pressure in the future (Novitzky et al., 2015). 
 The promise of economic advantage and relief of health systems cannot occur 
unless appropriate market assessment tools for of AAL technologies are developed. 
The procurement and assessment of AAL technologies is a complex multi-layered 
process, particularly in the context of fragmented European health systems. Although 
technology assessment itself is not a new concept, it has a documented history 
spanning over 60 years, its application in the present context is somewhat new and 
undocumented. The fundamentals of a technology assessment however remain the 
same. It must consider cost, effectiveness and readiness of the technology for a given 
market. In doing so all stakeholders, bearers of costs and market alternatives should 
be reviewed (National Library of Medicine, 2004; O’Donnell et al., 2009; National 
Institute for Health Research, 2017). It is a multidisciplinary field. In this present context 
it includes technological analysis across medical, social, ethical and economic arenas 
of development. While policy relating to diffusion and use of health technology must 
also be considered (INAHTA, 2017). 
 Work carried out in other jurisdictions such as the UK was reviewed as part of the 
background for adopting an approach to impact assessment for the AAL supports. 
Although there was anecdotal evidence that procurement was being involved in the 
HTA in the UK, when the implementation documents were reviewed there was only 
one reference to purchasing in the NHS “Guide to the multiple technology appraisal 
process” published in October 2009. 
 In Ireland for example HTA is governed by HIQA (Health Information & Quality 
Authority, 2010). Similar to the UK documentation, in all of HIQA’s 3 recent publications 
the role of procurement in helping to examine the cost benefits or the economic 
evaluation is not mentioned (Health Information & Quality Authority, 2017). 
Procurement as such is not seen as having a role to play in the engagement with 
suppliers of medical devices, rather the role falls to clinicians and specialist staff. This 
lack of linkage between the early involvement of procurement and the development 
of innovation goes counter to previous government recommendations for the 
procurement of innovation. This approach may indicate a lack of consistency 
between government policy and actual implementation. 
 This work offers insight into the challenges that any Pan-European project with a 
healthcare delivery focus will be faced with. After reviewing various health systems 
and considering that the history of Europe begins together different forms of 
healthcare governance from Bismarck models to more centralised models, it 
becomes clear that integration of a ‘one size fits all’ model is almost impossible to 
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Janssen et al., 2013; Cusack et al., 2009) does show that technology assessments can 
coincide with route to market solutions, this research is however void of cases where 
such a disparate model as is found in Europe, has been catered for. As such the 
present study only serves to highlight the need for bespoke models and further 
research in this present context.    
 The Horizon 2020 projects referred to in this paper are being undertaken at an 
opportune time. Both projects require the bespoke development of total cost of 
ownership tools. At project maturity both solutions will have trialled suitable total cost 
of owner ship tools and commercialisation routes. This knowledge, in conjunction with 
a review of various European health systems it has made it clear that developing a 
bespoke total cost of ownership tool for European-wide AAL technological solutions is 
imperative to their successful diffusion through health systems. This paper will now 




Due to time restrictions and the nascence of research in the area of TCO models being 
applied to AAL technology assessment a secondary research approach was 
employed for this paper (Bryman and Bell, 2007). A literature review of extant TCO 
models and their application to AAL was performed with the models applicable to 
eHealth solutions then presented in the paper.  
 A traditional review of literature on small and medium-sized enterprises (SMEs), 
public procurement processes and related government policies was undertaken. As 
the direction of the research was undetermined at project initiation a traditional 
scoping review methodology was employed as advised by Jesson, Matheson and 
Lacey (2011).  In keeping with the method, the previous experiences of the researcher 
were called on to develop a base. Highly cited papers by contributors in leading 
academic journals were consulted. In addition, global organisations such as the 
Organisation for Economic Co-operation and Development (OECD) were also 
examined for outputs relating to key search terms and themes. 
 
Results 
The World Health Organisation states that health technology assessment involves a 
systematic approach to the evaluation of properties, effects and impacts of a 
technology. It is a multidisciplinary task that incorporates social, economic, 
organisational and ethical considerations with an objective to inform policy decision 
making (World Health Organisation, 2017). Insights from this research paper indicate 
that there is an alarming lack of alignment between the Health Technology 
Assessment (HTA) process and the overall procurement process. Where a normal 
technology assessment is required to begin with a review of similar historical case 
examples it was found that no such practice is mirrored when medical devices are 
being assessed. In addition, where a traditional technology assessment would include 
the consultation of various stakeholders, health technology assessments failed to 
include key stakeholders such as biomedical staff. 
 The dichotomy of European health systems, between public and private systems of 
delivery, elevates the role and influence of the assessment process relating to eHealth 
services. As assessors must evaluate the costs associated with the procurement of 
eHealth solutions during the technology assessment process, a clear understanding 
must be obtained of where costs gather along a product lifecycle; on the public or 
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 A big picture understanding of product or service life cycles is therefore required to 
complete a technology assessment. Models that assess the life cycle of a technology 
must reflect the particular industry and body of stakeholders for which it is intended.  
 The procurement process is not always fully documented, particularly in the public 
sector. In an effort to harmonise methodologies Caldwell et al. (2007) has outlined a 
procurement process based on Van Weeles (2004) model. The result is a six-stage 
process; specification, supplier selection, contracting, ordering, expediting and 
follow-up / evaluation.  
 The assessment and procurement of AAL technologies is particularly complex. 
Consideration must be given to existing medical support infrastructure, the supply of 
utility services such as electricity, cloud services, staff training and implementation. In 
some institutions the assessment and procurement of AAL technologies can be 
perceived as a strategic activity, necessitating a medium to long-term scope. Aiding 
this process the Total Cost of Ownership tool (TCO) (Hurkens and Wynstra, 2006) is used 
to understand indirect costs. This allows organisations to assess the lowest possible cost 
to be incurred when in negotiation with suppliers (Van Weele, 2004). 
 Ellram and Siferd (1998) have identified three segments to successful TCO analysis; 
operational, tactical and strategic. Through the TCO analysis organisations can 
uncover opportunities to either avoid or reduce cost. Due to the fragmented nature 
of European health systems this can prove to be a difficult task. Not only is there a lack 
of a common framework for deployment but cost structures vary from state to state. 
 TCO analysis highlights the many layers involved in the assessment of a technology. 
For example, it is often the case that the assessment and acquisition of an AAL 
technology includes the considered procurement of a product and service. As a 
result, performing TCO analysis during a technology assessment not only informs 
matters relating to direct and indirect cost (Leenders et al., 2006) but also elucidates 
a number of other influential factors: (i) Cost reduction opportunities; (ii) Supplier 
evaluation and selection criteria; (iii) Data for negotiations; (iv) Points to focus suppliers 
on cost reduction opportunities; (v) Advantages of expensive, high quality items; (vi) 
Clarification and definition of supplier performance expectations; (vii) A long term 
supply perspective, and (viii) Forecasting for future performance. 
 There are a number of methods for estimating TCO. Organisations generally choose 
a TCO approach from one of two overriding methodologies; a standardised TCO tool 
approach or the development of a bespoke tool.  
 Hurkens and Wynstra (2006) highlight a number of methods to use when estimating 
costs. The first of these, the monetary based method, which allocates the costs of 
purchasing a service or product to the different true costs of components in the 
offering.  
 The second method is the cost-ratio or value-based method (Carr and Ittner, 1992; 
Ellram, 1995). This method incorporates the monetary method with qualitative 
performance data. By evaluating non-monetary data, a suppler rating score can be 
amassed, resulting in a total cost factor (Hurkens and Wynstra, 2006). 
 Shin and Benton (2007) offer a third model that introduces five performance factors; 
quality, delivery, technology, price and service. Suppliers are given a numeric rating, 
the highest being 1.0, indicating hidden cost of ownership. 
 Although there has been considerable research carried out on life cycle costing 
and total cost of ownership in other jurisdictions and within other product categories, 
there is little evidence of this being done on AAL supports. There is scope here for 
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Discussion 
This paper makes important contributions in three areas. The main finding of this paper 
is the existence of three TCO models that can support the assessment of AAL 
technologies (Hurkens and Wynstra, 2006; Carr and Ittner, 1992; Ellram, 1995; Shin and 
Benton, 2007). In addition, this research reveals strategic roles for TCO models that go 
beyond their initial purpose; providing data for negotiations, identification of cost 
reduction opportunities, supplier performance expectations, supplier selection criteria, 
advantages of expensive, high quality items and forecasting for future performance. 
Finally, it was found that existing models do not incorporate adequate collaboration 
between public and private entities. 
 A limitation of this paper is the lack of extant literature relating to TCO models and 
health technology assessment. Furthermore, there are limitations in the methodology 
employed; future studies should consider qualitative interviews with public and private 
practitioners.  
 The development and adoption of AAL technologies and health ICTs has grown 
exponentially in recent years (Angst and Agarwal, 2009; Statista, 2015; Glynn et al., 
2015). While extant scientific evidence is limited there are many positive purposes for 
which AAL technologies could be utilised for; they can alleviate challenges related to 
logistics for on-site visits by patient, clinician and care giver; they can facilitate 
rehabilitation sessions from the comfort of a patient’s home; they can reduce the 
economic burden that currently rests on stressed health care systems, caregivers and 
patients (Frontera et al., 2017).  
 The inherent benefit of these various technological developments is evident, 
despite this, barriers to use exist still exist (Bittner et al., 2015). Integration of multiple 
disciplines and technological solutions is still an issue in many health systems. Patients 
and citizens have expressed concerns over data ownership, confidentiality, privacy 
and security (Smith, Milberg and Burke, 1996; D’Arcy, Hovav and Galletta, 2009; Hong 
and Thong, 2013), while key stakeholders need a clear understanding of all underlying 
business commitments. These systems depend on multiple stakeholders having a clear 
and elucidated understanding of the technologies being developed and their 
infrastructure requirements. Essentially the success of these platforms is dependent on 
their technological acceptance and business case adoption (Harris et al., 2011). 
Therefore, it is imperative for researchers, practitioners and policy makers to have tools 
that assist in analysing the various business elements of these technologies in order to 
drive their adoption. 
 This paper has highlighted existing TCO models and the role TCO has in the 
development of a route to market framework for European wide healthcare delivery 
systems. As the proliferation of AAL technologies and cloud computing infrastructure 
continues, so too will the number of private and public collaborations. Healthcare 
systems across Europe display a diverse network of public and private partnerships; 
these include but are not limited to technological solutions, health care delivery 
systems and insurance packages. The revelation of existing TCO models, their strategic 
utility and the obvious room for public and private collaboration on TCO modelling 
should signal all stakeholders to embrace impending enterprise and research 
opportunities. Doing so will reduce the barriers to entry that currently exist for AAL 
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Conclusions 
This paper set out to explore the extant literature relating to TCO in the context of 
health technology assessment. In doing so it has uncovered a number of TCO models 
that can be readily adapted for health technology assessment. In addition, it was 
revealed that these TCO models can offer utility in scenarios beyond their initial 
purpose, that is to say they can offer valuable insight to the business negotiation 
process.  
 Although research exists on TCO models it should be noted that there is little analysis 
existing on its application in the context of AAL technologies to be diffused on a 
European-wide scale across varying health care systems. There is an opportunity for 
further research to develop this area particularly with regard to public and private 
sector collaborations. It is recommended that future TCO models be developed in 
conjunction with industry partners. It is also recommended that the TCO process be 
developed into a key award criterion when conducting AAL technology assessment 
and procurements, thus aiding long term strategic decision making. 
 In the immediate future this research carry’s a salient practical implication. It forms 
the basis of a TCO model that will be employed across a number of EU funded health 
projects. The various consortia will use the TCO model to assess risks, benefits, costs, 
opportunities and strategies associated with their respective health technologies. It 
will also be used when in negotiations with suppliers. This a key finding of this paper, in 
that there is utility beyond the traditional TCO model usage. 
 Finally, future research should consider a key limitation of this paper: no public or 
private TCO practitioners were approached for qualitative or quantitative analysis. 
Deeper analysis may uncover a bespoke TCO model that varies from those discussed 
in this paper. 
 
References 
1. Angst, C. M., Agarwal, R. (2009), “Adoption of Electronic Health Records in the Presence of 
Privacy Concerns: The Elaboration Likelihood Model and Individual Persuasion”, MIS 
Quarterly, Vol. 33, No. 2, pp. 339-370.  
2. Bittner, A. K., Wykstra, S. L., Yoshinaga, P. D., Li, T. (2015), “Telerehabilitation for people with 
low vision”, Cochrane Database of Systematic Reviews, No. 8.  
3. Bryman, A., Bell, E. (2007), Business Research Methods, Oxford University Press. 
4. Caldwell, N., Bakker, E., Read, J. (2007), “The purchasing process in public procurement”, 
in Knight, L., Harland, C., Telgen, J, Callender, G., McKen, J. (Eds.), Public Procurement 
International Cases and Commentary, England, Routledge. 
5. Carr, L. P., Ittner, C. D. (1992), “Measuring the cost of ownership”, Journal of Cost 
Management, Vol. 6, No. 3, pp. 42-51. 
6. Central Statistics Office (2012), Profile 2: Older and Younger, Dublin: Stationery Office.  
7. Cusack, C. M., Byrne, C., Hook, J. M., McGowan, J., Poon, E. G., Zafar, A. (2009), “A Health 
Information Technology Evaluation Toolkit: 2009 Update”, AHRQ Publication, No. 9, pp. 1-
59.  
8. D’Arcy, J., Hovav, A. and Galletta, D. (2009), “User awareness of security countermeasures 
and its impact on information systems misuse: A deterrence approach”, Information 
Systems Research, Vol. 20, No. 1, pp. 79-98.  
9. Ellram, L. M. (1995), “Total cost of ownership: An analysis approach for purchasing”, 
International Journal of Physical Distribution and Logistics, Vol. 25, No. 8, pp. 4-23. 
10. Ellram, L. M., Siferd, S. P. (1998), “Total Cost of Ownership: A key concept in Strategic Cost 
Management Decisions”, Journal of Business Logistics, Vol. 19, No. 1, pp. 55-84. 
11. Eurostat (2011), “Population projections”, European Commission, available at: 
http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Population_projections 






Business Systems Research | Vol. 10 No. 1 |2019 
12. Frontera, W. R., Bean, J. F, Damiano, D., Ehrlich-Jones, L., Fried-Oken, M., Jette, A., Jung, R., 
Lieber, R. L., Malec, J. F., Mueller, M. J., Ottenbacher, K. J., Tansey, K. E., Thompson, A. (2017), 
“Rehabilitation Research at the National Institutes of Health : Moving the Field Forward 
(Executive Summary)”, The American Journal of Occupational Therapy, Vol. 71, No. 3, pp. 
1–12. 
13. Glynn, L. Casey, M., Walsh, J., Hayes, P. S., Harte, R. P., Heaney, D. (2015), “Patients’ views 
and experiences of technology based self-management tools for the treatment of 
hypertension in the community: A qualitative study”, BMC Family Practice, Vol. 16, No. 1.  
14. Health Information & Quality Authority (2017), “HIQA publishes guide to health technology 
assessment”, available at: https://www.hiqa.ie/hiqa-news-updates/hiqa-publishes-guide-
health-technology-assessment  (25 November 2017). 
15. Health Information & Quality Authority (2010), “Guidelines for the Economic Evaluation of 
Health Technologies in Ireland”, available at: 
https://www.ispor.org/peguidelines/source/Ireland_Economic_Guidelines_2010.pdf  
(25 November 2017). 
16. Harris, P. R., Sillence, E., Briggs, P. (2011), “Perceived Threat and Corroboration: Key Factors 
That Improve a Predicitive Model of Trust in Internet-based Health Information and Advice”, 
Journal of Medical Internet Research, Vol. 13, No. 3. 
17. Hong, W., Thong, J. Y. L. (2013), “Internet privacy concerns: An integrated 
conceptualization and four empirical studies”, MIS Quarterly, Vol. 37, No. 1, pp. 275-298. 
18. Hurkens, K., Wynstra, F, (2006), “The concept “Total Value of Ownership”: A case study 
approach”, available at: www.iimm.org/knowledge_bank/IFPSM (7 June 2017). 
19. INAHTA (2017), “Health Technology Assessment”, available at: http://www.inahta.org/hta 
(25 November 17) 
20. Jacquemard, T., Novitzky, P., O'Brolcháin, F., Smeaton, A. F., Gordijn, B. (2014), “Challenges 
and opportunities of lifelog technologies: a literature review and critical analysis”, Science 
and Engineering Ethics, Vol. 20, No. 2, pp. 379-409.  
21. Janssen, R., Hettinga, M., Prins, H., Visser, S., Mengo, R., Krediet, I., Haaker, T., Bodenstaff, L. 
(2013), “Developing evidence guidelines for eHealth small and medium-sized enterprises”, 
in Proceedings of the Fifth International Conference on eHealth, Telemedicine, and Social 
Medicine (eTELEMED), pp. 92-95. 
22. Jesson, J., Matheson, L., Lacey, F. M. (2011), Doing Your Literature Review: Traditional and 
Systematic Techniques, SAGE Publications. 
23. Kidholm, K., Ekeland, A. G., Jensen, L. K., Rasmussen, J., Pedersen, C. D., Bowes, A., Flottorp. 
S. A., Bech, M. (2012), “Model for Assessment of Telemedicine Applications: Mast”, 
International Journal of Technology Assessment in Health Care, Vol. 28, No. 1, pp. 44-51.  
24. Leenders, M., Johnson, F., Flynn, A., Fearon, H. (2006), Purchasing and Supply Management, 
13th edition, New York, Irwin McGraw Hill. 
25. National Institute for Health Research (2017), “Health Technology Assessment”, available 
at: https://www.nihr.ac.uk/funding-and-support/funding-for-research-studies/funding-
programmes/health-technology-assessment/  (25 November 2017). 
26. National Library of Medicine (2004), “HTA 101: Introduction to Health Technology 
Assessment”, available at: https://www.nlm.nih.gov/nichsr/hta101/ta10103.html   
(25 November 2017). 
27. Novitzky, P., Smeaton, A. F., Chen, C., Irving, K., Jacquemard, T., O’Brolcháin, F., 
O’Mathúna, D., Gordijn, B. (2015), “A Review of Contemporary Work on the Ethics of 
Ambient Assisted Living Technologies for People with Dementia”, Science and Engineering 
Ethics, Vol. 21, No. 3, pp. 707-765.  
28. O’Donnell, J. C., Pham, S. V., Pashos, C. L., Miller, D. W., Smith, M. D. (2009), “Health 
Technology Assessment: Lessons Learned from Around the World—An Overview”, Value in 
Health, Vol. 12, No. 2, pp. S1-S5.  
29. SBJ (2011), “Statistical handbook of Japan 2011”, Statistics Bureau and the Director-General 
for Policy Planning of Japan, available at: 
http://www.stat.go.jp/english/data/handbook/index.htm (7 June 2017). 
30. Shin, H., Benton, W. C. (2007), “A quantity discount approach to supply chain 






Business Systems Research | Vol. 10 No. 1 |2019 
31. Smith, H. J., Milberg, S. J., Burke, S. J. (1996), “Information Privacy: Measuring Individuals’ 
Concerns about Organizational Practices”, MIS Quarterly, Vol. 20, No. 2, pp. 167-196.  
32. Statista (2015), “Statistics and facts about mobile app usage”, available at: 
http://www.statista.com/topics/1002/mobile-app-usage (22 June 2016). 
33. Van Weele, A. J. (2004), Purchasing and Supply Chain Management, 4th edition, Cengage 
Learning Business Press.  
34. World Health Organisation (2016), “From Innovation to Implementation: eHealth in the WHO 
European Region“, available at: http://www.euro.who.int/en/publications/abstracts/from-
innovation-to-implementation-ehealth-in-the-who-european-region-2016 (7 June 2017). 
35. World Health Organisation (2017), “Health technology assessment”, available at: 




About the authors 
 
Eoghan McConalogue is a PhD candidate and Assistant Professor at Dublin City 
University. His research has a focus on eHealth technologies, self-disclosure and trust. 
Author can be contacted at eoghan.mcconalogue@dcu.ie. 
 
Dr. Paul Davis is a lecturer in the School of Business at Dublin City University. He is a past 
council member and past president for the Irish Institute of Purchasing and Materials 
Management. He has previously been seconded to the Health Service Executive ICT 
Strategy Unit, advising on procurement strategy and market engagement. Dr Davis 
was lead PI in DCU for the Winning in Tendering Project. The project has a budget of 
€3.7 million euro. He is currently PI for the following H2020 projects in DCU Business 
School: Pathway, Magic, Inlife. The author can be contacted at paul.davis@dcu.ie.  
 
Prof Regina Connolly has significant expertise in healthcare technology impact 
assessment as well as eHealth business model development and is a Lead Investigator 
in several international Ambient Healthcare Technology research projects that were 
awarded over €8.43 million in funding from the European Commission in 2014. She is 
also a lead investigator in a pre-commercial health technology procurement proposal 
that was awarded over €5.1 million in European funding in 2015. In 2016, the H2020 
public health research project (MIDAS) which she co-leads with Ulster University was 
awarded €3.1 million in European funding. The author can be contacted at 
regina.connolly@dcu.ie. 
